AUPH Annual Revenue
$175.51 M
+$41.48 M+30.95%
31 December 2023
Summary:
As of January 23, 2025, AUPH annual revenue is $175.51 million, with the most recent change of +$41.48 million (+30.95%) on December 31, 2023. During the last 3 years, it has risen by +$125.39 million (+250.20%). AUPH annual revenue is now at all-time high.AUPH Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AUPH Quarterly Revenue
$67.77 M
+$10.58 M+18.50%
30 September 2024
Summary:
As of January 23, 2025, AUPH quarterly revenue is $67.77 million, with the most recent change of +$10.58 million (+18.50%) on September 30, 2024. Over the past year, it has increased by +$10.58 million (+18.50%). AUPH quarterly revenue is now at all-time high.AUPH Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AUPH TTM Revenue
$220.36 M
+$13.26 M+6.40%
30 September 2024
Summary:
As of January 23, 2025, AUPH TTM revenue is $220.36 million, with the most recent change of +$13.26 million (+6.40%) on September 30, 2024. Over the past year, it has increased by +$13.26 million (+6.40%). AUPH TTM revenue is now at all-time high.AUPH TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AUPH Revenue Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +30.9% | +18.5% | +6.4% |
3 y3 years | +250.2% | +21.5% | +70.8% |
5 y5 years | +10000.0% | +21.5% | +70.8% |
AUPH Revenue High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +284.9% | at high | +213.4% | at high | +383.2% |
5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Aurinia Pharmaceuticals Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $67.77 M(+18.5%) | $220.36 M(+6.4%) |
June 2024 | - | $57.19 M(+13.7%) | $207.10 M(+8.2%) |
Mar 2024 | - | $50.30 M(+11.5%) | $191.41 M(+9.1%) |
Dec 2023 | $175.51 M(+31.0%) | $45.09 M(-17.3%) | $175.51 M(+10.5%) |
Sept 2023 | - | $54.52 M(+31.4%) | $158.85 M(-0.8%) |
June 2023 | - | $41.49 M(+20.6%) | $160.12 M(+9.1%) |
Mar 2023 | - | $34.41 M(+21.0%) | $146.81 M(+9.5%) |
Dec 2022 | $134.03 M(+193.9%) | $28.43 M(-49.0%) | $134.03 M(+3.9%) |
Sept 2022 | - | $55.78 M(+97.9%) | $129.00 M(+46.8%) |
June 2022 | - | $28.19 M(+30.4%) | $87.89 M(+32.5%) |
Mar 2022 | - | $21.63 M(-7.6%) | $66.32 M(+45.4%) |
Dec 2021 | $45.60 M(-9.0%) | $23.40 M(+59.6%) | $45.60 M(-36.9%) |
Sept 2021 | - | $14.67 M(+121.6%) | $72.23 M(+25.4%) |
June 2021 | - | $6.62 M(+624.3%) | $57.59 M(+12.9%) |
Mar 2021 | - | $914.00 K(-98.2%) | $51.00 M(+1.8%) |
Dec 2020 | $50.12 M(>+9900.0%) | $50.03 M(>+9900.0%) | $50.12 M(>+9900.0%) |
Sept 2020 | - | $29.00 K(0.0%) | $117.00 K(-63.2%) |
June 2020 | - | $29.00 K(-3.3%) | $318.00 K(0.0%) |
Mar 2020 | - | $30.00 K(+3.4%) | $318.00 K(0.0%) |
Dec 2019 | $318.00 K(-31.3%) | $29.00 K(-87.4%) | $318.00 K(0.0%) |
Sept 2019 | - | $230.00 K(+693.1%) | $318.00 K(-31.3%) |
June 2019 | - | $29.00 K(-3.3%) | $463.00 K(0.0%) |
Mar 2019 | - | $30.00 K(+3.4%) | $463.00 K(0.0%) |
Dec 2018 | $463.00 K(+10.8%) | $29.00 K(-92.3%) | $463.00 K(-0.2%) |
Sept 2018 | - | $375.00 K(+1193.1%) | $464.00 K(+293.2%) |
June 2018 | - | $29.00 K(-3.3%) | $118.00 K(-71.8%) |
Mar 2018 | - | $30.00 K(0.0%) | $418.00 K(0.0%) |
Dec 2017 | $418.00 K(+141.6%) | $30.00 K(+3.4%) | $418.00 K(0.0%) |
Sept 2017 | - | $29.00 K(-91.2%) | $418.00 K(-0.5%) |
June 2017 | - | $329.00 K(+996.7%) | $420.00 K(+187.7%) |
Mar 2017 | - | $30.00 K(0.0%) | $146.00 K(-15.6%) |
Dec 2016 | $173.00 K(-26.4%) | $30.00 K(-3.2%) | $173.00 K(-13.5%) |
Sept 2016 | - | $31.00 K(-43.6%) | $200.00 K(-11.5%) |
June 2016 | - | $55.00 K(-3.5%) | $226.00 K(-1.7%) |
Mar 2016 | - | $57.00 K(0.0%) | $230.00 K(-2.1%) |
Dec 2015 | $235.00 K(-15.5%) | $57.00 K(0.0%) | $235.00 K(-4.5%) |
Sept 2015 | - | $57.00 K(-3.4%) | $246.00 K(-5.7%) |
June 2015 | - | $59.00 K(-4.8%) | $261.00 K(-4.4%) |
Mar 2015 | - | $62.00 K(-8.8%) | $273.00 K(-1.8%) |
Dec 2014 | $278.00 K(-71.3%) | $68.00 K(-5.6%) | $278.00 K(-69.8%) |
Sept 2014 | - | $72.00 K(+1.4%) | $922.00 K(-1.3%) |
June 2014 | - | $71.00 K(+6.0%) | $934.00 K(-1.5%) |
Mar 2014 | - | $67.00 K(-90.6%) | $948.00 K(-2.2%) |
Dec 2013 | $969.00 K(-84.3%) | $712.00 K(+747.6%) | $969.00 K(+182.3%) |
Sept 2013 | - | $84.00 K(-1.2%) | $343.20 K(-1.0%) |
June 2013 | - | $85.00 K(-3.4%) | $346.60 K(-1.0%) |
Mar 2013 | - | $88.00 K(+2.1%) | $350.10 K(-94.2%) |
Dec 2012 | $6.16 M(+563.9%) | $86.20 K(-1.4%) | $6.08 M(-0.6%) |
Sept 2012 | - | $87.40 K(-1.2%) | $6.11 M(-6.8%) |
June 2012 | - | $88.50 K(-98.5%) | $6.56 M(-1.0%) |
Mar 2012 | - | $5.81 M(+4744.4%) | $6.62 M(+600.3%) |
Dec 2011 | $927.50 K | $120.00 K(-77.6%) | $945.50 K(-15.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2011 | - | $534.80 K(+250.0%) | $1.12 M(+31.8%) |
June 2011 | - | $152.80 K(+10.8%) | $852.10 K(-59.7%) |
Mar 2011 | - | $137.90 K(-53.7%) | $2.11 M(-38.0%) |
Dec 2010 | $3.42 M(+34.4%) | $297.80 K(+13.0%) | $3.41 M(-24.5%) |
Sept 2010 | - | $263.60 K(-81.4%) | $4.51 M(-9.8%) |
June 2010 | - | $1.41 M(-1.3%) | $5.00 M(+34.3%) |
Mar 2010 | - | $1.43 M(+2.1%) | $3.72 M(+49.2%) |
Dec 2009 | $2.54 M(-34.4%) | $1.40 M(+85.8%) | $2.50 M(+110.4%) |
Sept 2009 | - | $755.00 K(+461.8%) | $1.19 M(-62.1%) |
June 2009 | - | $134.40 K(-34.0%) | $3.13 M(-11.8%) |
Mar 2009 | - | $203.50 K(+117.9%) | $3.55 M(-9.2%) |
Dec 2008 | $3.88 M(+66.1%) | $93.40 K(-96.5%) | $3.91 M(-11.8%) |
Sept 2008 | - | $2.70 M(+386.9%) | $4.44 M(+93.9%) |
June 2008 | - | $555.10 K(-1.3%) | $2.29 M(+5.8%) |
Mar 2008 | - | $562.50 K(-8.7%) | $2.16 M(-2.0%) |
Dec 2007 | $2.33 M(-33.7%) | $616.30 K(+11.2%) | $2.21 M(-1.0%) |
Sept 2007 | - | $554.00 K(+29.0%) | $2.23 M(+1.6%) |
June 2007 | - | $429.30 K(-29.1%) | $2.19 M(-18.8%) |
Mar 2007 | - | $605.90 K(-5.0%) | $2.70 M(-22.0%) |
Dec 2006 | $3.52 M(+199.1%) | $638.00 K(+22.8%) | $3.46 M(+8.4%) |
Sept 2006 | - | $519.40 K(-44.6%) | $3.20 M(+8.7%) |
June 2006 | - | $937.00 K(-31.6%) | $2.94 M(+33.2%) |
Mar 2006 | - | $1.37 M(+269.7%) | $2.21 M(+91.1%) |
Dec 2005 | $1.18 M(-7.5%) | $370.30 K(+41.2%) | $1.15 M(+11.0%) |
Sept 2005 | - | $262.30 K(+28.5%) | $1.04 M(-0.0%) |
June 2005 | - | $204.10 K(-35.7%) | $1.04 M(-4.7%) |
Mar 2005 | - | $317.40 K(+24.2%) | $1.09 M(-12.1%) |
Dec 2004 | $1.27 M(-83.4%) | $255.50 K(-2.7%) | $1.24 M(-22.5%) |
Sept 2004 | - | $262.50 K(+2.9%) | $1.60 M(-2.7%) |
June 2004 | - | $255.00 K(-45.5%) | $1.65 M(-79.2%) |
Mar 2004 | - | $467.50 K(-24.1%) | $7.92 M(+3.3%) |
Dec 2003 | $7.66 M(-35.7%) | $615.60 K(+100.6%) | $7.67 M(+4.3%) |
Sept 2003 | - | $306.90 K(-95.3%) | $7.35 M(-34.6%) |
June 2003 | - | $6.53 M(+2922.9%) | $11.23 M(+10.6%) |
Mar 2003 | - | $216.00 K(-28.1%) | $10.16 M(-16.4%) |
Dec 2002 | $11.92 M(+125.0%) | $300.40 K(-92.8%) | $12.15 M(+2.5%) |
Sept 2002 | - | $4.19 M(-23.2%) | $11.85 M(+49.6%) |
June 2002 | - | $5.46 M(+147.7%) | $7.92 M(+165.3%) |
Mar 2002 | - | $2.20 M(+749.1%) | $2.98 M(+95.2%) |
Dec 2001 | $5.30 M(+486.8%) | - | - |
Aug 2001 | - | $259.40 K(-50.3%) | $1.53 M(+0.7%) |
May 2001 | - | $522.30 K(+16.6%) | $1.52 M(+42.9%) |
Feb 2001 | - | $447.80 K(+49.7%) | $1.06 M(+19.3%) |
Nov 2000 | $902.80 K(-30.0%) | $299.20 K(+20.1%) | $890.80 K(-12.0%) |
Aug 2000 | - | $249.20 K(+273.6%) | $1.01 M(+5.0%) |
May 2000 | - | $66.70 K(-75.8%) | $963.60 K(-17.5%) |
Feb 2000 | - | $275.70 K(-34.4%) | $1.17 M(-9.5%) |
Nov 1999 | $1.29 M(+4.3%) | $420.50 K(+109.5%) | $1.29 M(+48.4%) |
Aug 1999 | - | $200.70 K(-26.0%) | $869.70 K(+30.0%) |
May 1999 | - | $271.30 K(-31.8%) | $669.00 K(+68.2%) |
Feb 1999 | - | $397.70 K | $397.70 K |
Nov 1998 | $1.24 M | - | - |
FAQ
- What is Aurinia Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual revenue year-on-year change?
- What is Aurinia Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly revenue year-on-year change?
- What is Aurinia Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals TTM revenue year-on-year change?
What is Aurinia Pharmaceuticals annual revenue?
The current annual revenue of AUPH is $175.51 M
What is the all time high annual revenue for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual revenue is $175.51 M
What is Aurinia Pharmaceuticals annual revenue year-on-year change?
Over the past year, AUPH annual revenue has changed by +$41.48 M (+30.95%)
What is Aurinia Pharmaceuticals quarterly revenue?
The current quarterly revenue of AUPH is $67.77 M
What is the all time high quarterly revenue for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly revenue is $67.77 M
What is Aurinia Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, AUPH quarterly revenue has changed by +$10.58 M (+18.50%)
What is Aurinia Pharmaceuticals TTM revenue?
The current TTM revenue of AUPH is $220.36 M
What is the all time high TTM revenue for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high TTM revenue is $220.36 M
What is Aurinia Pharmaceuticals TTM revenue year-on-year change?
Over the past year, AUPH TTM revenue has changed by +$13.26 M (+6.40%)